Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus vaccine clinical trial begins this month. WASHINGTON, July 15, 2024 (GLOBE NEWSWIRE) -- Sabin Vaccine ...

PRINCETON, N.J., April 11, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...

Despite the known skepticism of its leader Robert F Kennedy Jr, the Department of Health and Human Services quietly announced last month two new vaccines aimed at addressing “material threats to ...

The FDA has granted orphan drug designation to the active ingredient in Soligenix Inc.’s Suvax, a subunit protein vaccine of recombinantly expressed Sudan ebolavirus (SUDV) glycoprotein, for the ...

The vaccine candidate has been shown to be stable for at least 2 years when stored at temperatures of 40 degrees Celsius (104 degrees Fahrenheit). The Food and Drug Administration (FDA) has granted ...

Formulation optimization focused on safety and thermostability of a single-vial bivalent Sudan Ebola virus and Marburg Virus Vaccine presented by Professor Axel Lehrer, University of Hawaiʽi at Mānoa ...

PRINCETON, N.J., June 14, 2024 /PRNewswire/ -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat ...

A research team has found that obeldesivir, a prodrug candidate similar to the antiviral remdesivir, had a strong postexposure prophylactic effect in nonhuman primates against the species known as ...

Please provide your email address to receive an email when new articles are posted on . HOUSTON — Uganda rapidly scaled up screening during a rare outbreak of Ebola virus in 2022 using a plan that ...

Provides SuVax™ Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval The U.S. Orphan Drug Act is intended to assist and encourage companies to develop safe and effective ...